Atlas Trials

Tumor-Targeted-NIR-II Fluorescent Molecular Probes for the Identification of Breast Cancer Tissue and SLN Metastatic Status

Clinical trial NCT06713161 · RECRUITING

Trial details

NCT number
NCT06713161
Sponsor
Yunnan Cancer Hospital
Status
RECRUITING
Study type
OBSERVATIONAL
Breast CancerSentinel Lymph NodeMetastasesMargin Assessment
Start date
2024-09-01
Primary completion
2025-08-25
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.